Tag Archives: HMO

Novonesis Advances Growth Strategy with Acquisition of Key Biosolutions Facility in Thailand

(IN BRIEF) Novonesis has agreed to acquire a fermentation production facility in Rayong, Thailand from Meihua for approximately USD 50 million, expanding its footprint in Southeast Asia. The facility will enhance the company’s global production capabilities and support its long-term … Read the full press release

WACKER and BENEO Partner to Bring 2’-Fucosyllactose (2’-FL) to European Market for Infant Nutrition

(IN BRIEF) WACKER and BENEO have launched 2’-Fucosyllactose (2’-FL), a human milk oligosaccharide (HMO), for early-life nutrition. Available initially in Europe, this product is part of a strategic partnership aimed at enhancing the availability of HMOs in the market. The … Read the full press release

Chr. Hansen’s MyOli™ 6’-SL HMO Receives EU Approval for Infant Formula and Follow-On Formula

(IN BRIEF) Chr. Hansen has received approval from the EU for their 6’-SL HMO, the final addition to their MyOli™ 5 HMO Mix. This authorization allows the highest use level of 6’-SL in infant formula and follow-on formula in the … Read the full press release

DSM adds Human Milk Oligosaccharides (HMO) to its portfolio with the acquisition of Glycom

(PRESS RELEASE) HEERLEN, the Netherlands, 21-Feb-2020 — /EuropaWire/ — Royal DSM has reached agreement to acquire Glycom A/S (“Glycom”), the world’s leading supplier of Human Milk Oligosaccharides (HMO). The transaction, worth €765 million, represents an EV/EBITDA multiple of 20.6x based … Read the full press release